-
Thematic Analysis
NewPsychedelics Therapeutics Development and Trends, 2024
This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. The report identifies the broader changes within the evolving psychedelic industry, facilitating informed decision-making for relevant sectors.
-
Sector Analysis
NewPCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
PCR Systems Market Report Overview The PCR Systems market size was $700.3 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Polymerase Chain Reaction (PCR) systems are used to perform nucleic acid amplification, typically in support of investigations concerning the diagnosis or prognosis of cancer or infectious disease. PCR Systems Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the PCR Systems Market Forecast Download a Free...
-
Thematic Analysis
NewQuantum Computing in Aerospace, Defense and Security – Thematic Intelligence
Quantum Computing in Aerospace and Defense Thematic Report Overview Quantum computing aims to use the counterintuitive behavior of sub-atomic particles to spawn computers of mind-boggling power. Quantum computers can simulate large, uncertain, complicated systems in seconds, including the weather, financial markets, chemical reactions, molecules, and neurons in the human brain. In the aerospace and defense industry quantum capabilities are theorized to have applications in sensing, communications, computing, navigation, and electronic warfare, with the unique properties of quantum mechanics enhancing situational...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naronapride in Corrosive Esophagitis (Erosive Esophagitis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naronapride in Corrosive Esophagitis (Erosive Esophagitis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Naronapride in Corrosive Esophagitis (Erosive Esophagitis) Drug Details: Naronapride is...
-
Thematic Analysis
NewRegulated mHealth Apps – Thematic Intelligence
Regulated mHealth Apps Thematic Report Overview Mobile health apps, often abbreviated as mHealth apps, are software applications designed for mobile devices such as smartphones and tablets that offer various health-related functionalities. These apps cater to a wide range of needs, from general health and wellness tracking to specific medical condition management. They encourage patients to take control of their health by tracking their medical data, accessing their medical records, and communicating with healthcare providers. While there are several categories of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Biologic For Crohn’s Disease in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Biologic For Crohn's Disease in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Biologic For Crohn's Disease in Crohn's Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CX-904 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CX-904 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CX-904 in Colorectal Cancer Drug Details: CX-904 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CX-904 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CX-904 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CX-904 in Solid Tumor Drug Details: CX-904 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olafertinib in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olafertinib in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olafertinib in Non-Small Cell Lung Cancer Drug Details: Olafertinib is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-859 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-859 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ION-859 in Parkinson's Disease Drug Details: ION-859 (IONISBIIB-7Rx) is under development for...